FindTrial
Sign In

A medical records based study for distribution characteristics of molecular typing in endometrial carcinoma

Distribution characteristics of molecular typing in endometrial carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049837
Enrollment
Unknown
Registered
2021-08-10
Start date
2021-08-07
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Case series:No

Sponsors

Beijing Obstetrics and Gynecology Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Conform to the diagnosis of endometrial cancer; 2. The first diagnosis and initial treatment; 3. The patient agrees and voluntarily signs the informed consent; 4. The corresponding medical records of cancer tissues in the specimen bank are complete, and follow-up can be carried out.

Exclusion criteria

Exclusion criteria: Follow-up was not possible.

Design outcomes

Primary

MeasureTime frame
Pole genetic testing;Immunohistochemical analysis;—

Countries

China

Contacts

Public ContactMiao Jinwei

Beijing Obstetrics and Gynecology Hospital Capital Medical University

miaojinweigyn@163.com+86 1851805638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026